Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
Omicron KP.2 variant adapted vaccine COMIRNATY® is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks…. Read More




